resveratrol has been researched along with Metabolic Syndrome in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (8.82) | 29.6817 |
| 2010's | 51 (75.00) | 24.3611 |
| 2020's | 11 (16.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alesci, A; Cicero, N; Fumia, A; Giorgianni, F; Nicosia, N; Santini, A | 1 |
| Elamir, AM; Elsayed, AM; Golam, RM; Ibrahim, NA; Merzeban, DH; Shamardl, HAMA | 1 |
| Aamir, M; Fatima, F; Fatima, S; Hafeez, A; Ijaz, A; Khan, DA | 1 |
| Akbari, M; Asemi, Z; Dadgostar, E; Ghaderi, A; Haghighat, N; Kolahdooz, F; Lankarani, KB; Mansournia, MA; Tabrizi, R; Tamtaji, OR | 1 |
| Carreón-Torres, E; Castrejón-Téllez, V; Díaz-Díaz, E; Guarner-Lans, V; Pérez-Torres, I; Rubio-Ruiz, ME; Villegas-Romero, M | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Andrade, JMO; Barcala-Jorge, AS; Batista-Jorge, GC; de Paula, AMB; Guimarães, ALS; Lelis, DF; Santos, SHS; Silveira, MF | 1 |
| Kornicka-Grabowska, K; Marycz, K; Mularczyk, M; Siwinska, N; Weiss, C | 1 |
| Bavasso, CA; Iermoli, LV; Iermoli, RH; Lairion, F; Lazarowski, A; Manfredi Carabetti, Z; Merelli, A; Pastor, E; Pastor, I; Pastor, RF; Repetto, MG | 1 |
| El-Demerdash, E; Elsherbiny, DA; Gerges, SH; Wahdan, SA | 1 |
| Jayedi, A; Shab-Bidar, S; Zeraattalab-Motlagh, S | 1 |
| Bautista-Pérez, R; Cano-Martínez, A; Carreón-Torres, E; Castrejón-Téllez, V; Díaz-Díaz, E; Flores-Estrada, J; Guarner-Lans, V; Pérez-Torres, I; Rubio-Ruíz, ME | 1 |
| Chen, Y; Li, XX; Wang, T; Zhou, Z | 1 |
| Brianso-Llort, L; Hammond, GL; Saez-Lopez, C; Selva, DM; Simó, R; Torres-Torronteras, J | 1 |
| Akter, J; An, HJ; Chun, P; Chung, HY; Jeong, HO; Kim, DH; Kim, MJ; Kim, SJ; Lee, B; Lee, EK; Lee, HJ; Moon, HR; Moon, KM; Ullah, S; Yang, J | 1 |
| Bircan, FS; Pasaoglu, OT; Turkozkan, N; Yilmaz Demirtas, C | 1 |
| Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, WL; Yu, HR | 1 |
| Bairwa, SC; Dyck, JRB; Kim, TT; Levasseur, J; Madsen, K; Parajuli, N; Schertzer, JD; Soltys, CM; Sung, MM; Wishart, DS | 1 |
| Irwin-Houston, JM; Kornicka, K; Marycz, K; Weiss, C | 1 |
| Hsu, CN; Tain, YL | 1 |
| Carpéné, C; Chaplin, A; Mercader, J | 1 |
| Akbari, M; Asemi, Z; Dadgostar, E; Lankarani, KB; Mirhosseini, N; Peymani, P; Tabrizi, R; Tamtaji, OR | 1 |
| Hosseinzadeh, H; Imenshahidi, M; Rameshrad, M; Razavi, BM | 1 |
| Hou, CY; Huang, LT; Tain, YL; Yu, HR | 1 |
| Gupta, SC; Kaschula, CH; Maiti, P; Rai, V; Singh, AP; Singh, R; Verma, SS | 1 |
| Asgary, S; Farzaei, MH; Karimi, R; Momtaz, S; Naseri, R | 1 |
| Houston, JMI; Kornicka, K; Marycz, K; Röcken, M; Weiss, C | 1 |
| Akbari, M; Asemi, Z; Dadgostar, E; Jamilian, M; Kolahdooz, F; Lankarani, KB; Mirzaei, H; Tabrizi, R; Tamtaji, OR | 1 |
| Cicero, A; Fogacci, F; Fogacci, S | 1 |
| Ahn, MH; Baek, SH; D'Souza, R; Hong, ST; Hwang, E; Jeon, JS; Jeon, Y; Kang, HJ; Kim, HJ; Kim, SY; Lee, DW; Lee, HS; Lee, SW; Moon, E; Ryu, HS; Seo, CS; Shin, WC | 1 |
| Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sellke, FW | 1 |
| Bilski, A; Chen, TY; Cheng, A; Cooper, B; Ferruzzi, MG; Freire, D; Gong, B; Ho, L; Janle, EM; Nguyen, T; Pasinetti, GM; Roman, J; Simon, JE; Song, BJ; Talcott, ST; Tang, C; Varghese, M; Wang, J; Wu, Q | 1 |
| Balduzzi, V; Bernardini, N; La Viola, G; Mancini, MT; Nicolucci, F; Pampena, R; Potenza, C; Proietti, I; Skroza, N; Soccodato, V; Tolino, E; Zuber, S | 1 |
| Koh, KK; Lim, S; Quon, MJ | 1 |
| Avogaro, A; Cattelan, A; Ceolotto, G; De Kreutzenberg, SV; Fabricio, AS; Fadini, GP; Gion, M; Semplicini, A; Squarcina, E | 1 |
| Bianchi, C; Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sadek, AA; Sellke, FW | 1 |
| González-Ortiz, M; Lizárraga-Valdez, R; Martínez-Abundis, E; Méndez-del Villar, M; Pérez-Rubio, KG | 1 |
| Harsløf, T; Kjær, TN; Langdahl, BL; Ornstrup, MJ; Pedersen, SB | 1 |
| Koter-Michalak, M; Maćczak, A; Pytel, E; Sicińska, P | 1 |
| Cohen, AS; Hougaard, DM; Jørgensen, JO; Kjaer, TN; Neghabat, S; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B | 1 |
| Badger, RS; Biesinger, S; Jalili, T; Michaels, HA; Qian, Y; Quadros, AS; Rabovsky, AB | 1 |
| Baggen, J; Chen, WJ; Diamant, M; Favre, J; Fontijn, R; Garcia-Vallejo, JJ; Horrevoets, AJ; Koolwijk, P; Leyen, TA; Musters, R; Serné, E; van der Pouw Kraan, T; van Genugten, RE; van Golen, LW; Yildirim, C | 1 |
| Dain, A; Das, UN; Diaz-Gerevini, GT; Eynard, AR; Repossi, G; Tarres, MC | 1 |
| Castrejón-Tellez, V; Cruz-Lagunas, A; Guarner-Lans, V; Pérez-Hernández, N; Pérez-Torres, I; Rodríguez-Pérez, JM; Rubio-Ruiz, ME; Vargas-Alarcón, G | 1 |
| Al Sayah, L; Bachschmid, MM; Cohen, RA; Fry, JL; Seta, F; Van Roy, I; Weisbrod, RM; Weng, X | 1 |
| Jessen, N; Jørgensen, JOL; Kjær, TN; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B; Stødkilde-Jørgensen, H | 1 |
| Kjær, TN; Korsholm, AS; Ornstrup, MJ; Pedersen, SB | 1 |
| Lam, KS; Liu, L; Wang, Y; Xu, A | 1 |
| Cacciapuoti, F | 1 |
| Galisteo, M; Morón, R; Rivera, L; Zarzuelo, A | 1 |
| Arora, R; Sadruddin, S | 1 |
| Avogaro, A; Bortoluzzi, A; Ceolotto, G; Cobelli, C; Dalla Man, C; de Kreutzenberg, SV; Fadini, GP; Papparella, I; Semplicini, A | 1 |
| Chaudray, M; Chu, LM; Clements, RT; Coady, MA; Han, Y; Laham, RJ; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW | 1 |
| Beaudeux, JL; Giral, P; Nivet-Antoine, V | 1 |
| Weng, J; Xia, X | 1 |
| Cherniack, EP | 1 |
| Chu, LM; Clements, RT; Feng, J; Han, Y; Manning, WJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW | 1 |
| Bianchi, C; Burgess, TA; Chu, LM; Robich, MP; Sellke, FW | 1 |
| Davidge, ST; Dolinsky, VW; Dyck, JR; Morton, JS; Rueda-Clausen, CF | 1 |
| Chu, LM; Lassaletta, AD; Robich, MP; Sellke, FW | 1 |
| Das, DK; Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H | 1 |
| Bagul, PK; Banerjee, SK; Bastia, T; Chakravarty, S; Madhusudana, K; Matapally, S; Middela, H; Padiya, R; Reddy, BR | 1 |
| Baños, G; El-Hafidi, M; Pérez-Torres, I; Ruiz-Ramírez, A | 1 |
| Burgess, TA; Chu, LM; Feng, J; Han, Y; Laham, RJ; Leber, MP; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW | 1 |
| Bianchi, C; Chu, LM; Elmadhun, NY; Lassaletta, AD; Sellke, FW | 1 |
| Hardy, DB; Ma, N | 1 |
| Chen, D; Guarente, L | 1 |
25 review(s) available for resveratrol and Metabolic Syndrome
| Article | Year |
|---|---|
Resveratrol and Immune Cells: A Link to Improve Human Health.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; COVID-19 Drug Treatment; Dendritic Cells; Humans; Immunity, Cellular; Macrophages; Metabolic Syndrome; Neuroinflammatory Diseases; Resveratrol; Sirtuin 1 | 2022 |
The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
Topics: Animals; Cholesterol; Humans; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol; Triglycerides | 2020 |
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions.
Topics: Curcumin; Humans; Insulin Resistance; Liver; Liver Transplantation; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Plant Preparations; Resveratrol; Risk Factors | 2021 |
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Insulin Resistance; Lipids; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Resveratrol | 2021 |
Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?
Topics: Animals; Antioxidants; Cellular Reprogramming; Humans; Metabolic Syndrome; Resveratrol | 2018 |
Resveratrol, Metabolic Syndrome, and Gut Microbiota.
Topics: Blood Pressure; Cholesterol; Clinical Trials as Topic; Diet, High-Fat; Dietary Fats; Gastrointestinal Microbiome; Gastrointestinal Tract; Homeostasis; Humans; Lipid Metabolism; Meta-Analysis as Topic; Metabolic Syndrome; Observational Studies as Topic; Oxidative Stress; Resveratrol; Triglycerides | 2018 |
The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
Topics: Biomarkers; Dietary Supplements; Humans; Metabolic Syndrome; Oxidative Stress; Randomized Controlled Trials as Topic; Resveratrol | 2018 |
The Effects of Resveratrol in the Treatment of Metabolic Syndrome.
Topics: Animals; Disease Models, Animal; Humans; Metabolic Syndrome; Resveratrol | 2019 |
Health benefits of resveratrol: Evidence from clinical studies.
Topics: Animals; Antioxidants; Diabetes Mellitus; Humans; Metabolic Syndrome; Neoplasms; Obesity; Resveratrol | 2019 |
Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis.
Topics: Animals; Blood Pressure; Cholesterol; Humans; Metabolic Syndrome; Resveratrol; Waist Circumference | 2019 |
The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Adult; Aged; Blood Pressure; Dietary Supplements; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Treatment Outcome; Vasodilation; Vasodilator Agents | 2019 |
Modulation of adiponectin as a potential therapeutic strategy.
Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
[The use of various diet supplements in metabolic syndrome].
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Calcium; Caloric Restriction; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids, Omega-3; Garlic; Humans; Magnesium; Metabolic Syndrome; Obesity; Panax; Photinia; Phytotherapy; Plant Preparations; Resveratrol; Risk Reduction Behavior; Selenium; Stilbenes; Tea; Zinc | 2015 |
Beneficial action of resveratrol: How and why?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Cytochrome P-450 CYP1A1; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-17; Lipoxins; Metabolic Syndrome; NF-kappa B; Resveratrol; Stilbenes; Transcription Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2016 |
Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Wine | 2008 |
Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role.
Topics: Animals; Blood Coagulation; Caloric Restriction; Fibrinolytic Agents; Humans; Metabolic Syndrome; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes; Thrombosis; Ventricular Function, Left; Wine | 2009 |
Resveratrol: biologic and therapeutic implications.
Topics: Animals; Blood Glucose; Caloric Restriction; Cardiovascular Agents; Cardiovascular Diseases; Dietary Carbohydrates; Dietary Fats; Energy Intake; Homeostasis; Humans; Lipid Metabolism; Metabolic Syndrome; Molecular Structure; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2009 |
Resveratrol. Monograph.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Inflammation; Metabolic Syndrome; Neoplasms; Phytotherapy; Protective Agents; Resveratrol; Stilbenes | 2010 |
Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?
Topics: Adenylate Kinase; Caloric Restriction; Humans; Metabolic Syndrome; Phytotherapy; Plant Extracts; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Targeting metabolic syndrome: candidate natural agents.
Topics: Animals; Anthocyanins; Berberine; China; Curcumin; Female; Flavanones; Genistein; Ginsenosides; Humans; Male; Medicine, Traditional; Metabolic Syndrome; Mice; Momordica charantia; Phytotherapy; Plant Preparations; Prevalence; Randomized Controlled Trials as Topic; Rats; Resveratrol; Stilbenes | 2010 |
Polyphenols: planting the seeds of treatment for the metabolic syndrome.
Topics: Animals; Antioxidants; Catechin; Curcumin; Flavonoids; Humans; Metabolic Syndrome; Phenols; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2011 |
Resveratrol in the prevention and treatment of coronary artery disease.
Topics: Animals; Cardiovascular System; Coronary Artery Disease; Humans; Lipid Peroxidation; Lipids; Macrophages; Metabolic Syndrome; Muscle, Smooth, Vascular; Myocardial Reperfusion; Plaque, Atherosclerotic; Resveratrol; Stilbenes; Thrombosis; Wine | 2011 |
Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Curcumin; Hibiscus; Humans; Metabolic Syndrome; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2013 |
The fetal origins of the metabolic syndrome: can we intervene?
Topics: Antioxidants; Ascorbic Acid; Diet Therapy; Dietary Supplements; Exenatide; Fatty Acids, Omega-3; Female; Fetal Growth Retardation; Folic Acid; Humans; Hypoglycemic Agents; Melatonin; Metabolic Syndrome; Micronutrients; Peptides; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Resveratrol; Stilbenes; Venoms | 2012 |
SIR2: a potential target for calorie restriction mimetics.
Topics: Aging; Animals; Caenorhabditis elegans; Caloric Restriction; Enzyme Inhibitors; Humans; Longevity; Metabolic Syndrome; Models, Biological; Nerve Degeneration; Resveratrol; Saccharomyces cerevisiae; Sirtuins; Stilbenes | 2007 |
10 trial(s) available for resveratrol and Metabolic Syndrome
| Article | Year |
|---|---|
Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial.
Topics: Adult; Dietary Supplements; Humans; Metabolic Syndrome; MicroRNAs; Resveratrol | 2023 |
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program.
Topics: Administration, Oral; Adult; Dietary Supplements; Energy Metabolism; Female; Humans; Life Style; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Placebos; Resveratrol | 2020 |
Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment.
Topics: Adult; Animals; Antioxidants; Biomarkers; Body Mass Index; Cholesterol, HDL; Dietary Fats, Unsaturated; Dietary Supplements; Etanercept; Euphausiacea; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Metabolic Syndrome; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Resveratrol; Seeds; Selenium; Severity of Illness Index; Stilbenes; Thioctic Acid; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin E; Vitis | 2013 |
Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
Topics: Adiposity; Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Mexico; Middle Aged; Predictive Value of Tests; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides; Weight Loss | 2014 |
Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Antioxidants; Bone and Bones; Bone Density; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Patient Compliance; Resveratrol; Stilbenes | 2014 |
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
Topics: Aged; Androgens; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dihydrotestosterone; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Resveratrol; Stilbenes; Testosterone; Testosterone Congeners | 2015 |
A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.
Topics: Adult; Antihypertensive Agents; Antioxidants; Blood Pressure; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Magnoliopsida; Male; Metabolic Syndrome; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Phytochemicals; Phytotherapy; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2016 |
No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
Topics: Absorptiometry, Photon; Adipose Tissue; Antioxidants; Blood Glucose; Blood Pressure; Blotting, Western; Body Composition; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fructosamine; Humans; Insulin; Insulin Resistance; Interleukin-6; Intra-Abdominal Fat; Leptin; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolic Syndrome; Middle Aged; Muscle, Skeletal; Quadriceps Muscle; Real-Time Polymerase Chain Reaction; Receptors, Urokinase Plasminogen Activator; Resveratrol; Stilbenes; Triglycerides | 2017 |
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
Topics: Aged; Diabetes Mellitus; Drug Compounding; Endothelium, Vascular; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents | 2011 |
33 other study(ies) available for resveratrol and Metabolic Syndrome
| Article | Year |
|---|---|
Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1.
Topics: Adipokines; Adiposity; Animals; Diet; Diet, High-Fat; Insulin; Insulin-Like Growth Factor I; Lipids; Liver; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Rats; Resveratrol; Tumor Necrosis Factor-alpha | 2023 |
Effect of a Resveratrol/Quercetin Mixture on the Reversion of Hypertension Induced by a Short-Term Exposure to High Sucrose Levels Near Weaning and a Long-Term Exposure That Leads to Metabolic Syndrome in Rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Biomarkers; Disease Models, Animal; Drug Combinations; Gene Expression Regulation; Hypertension; Male; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Quercetin; Rats; Resveratrol; Sirtuin 1; Sucrose; Superoxide Dismutase; Weaning | 2020 |
Extracellular Microvesicles (MV's) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells.
Topics: Animals; Apoptosis; Autophagy; Azacitidine; Cell Survival; Cytokines; Endoplasmic Reticulum Stress; Extracellular Vesicles; Female; Horses; Inflammation; Male; Mesenchymal Stem Cells; Metabolic Syndrome; Oxidative Stress; Resveratrol | 2020 |
Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome.
Topics: Aged; Alkaloids; alpha-Tocopherol; Benzodioxoles; Biomarkers; C-Reactive Protein; Chronic Disease; Dietary Supplements; Female; Ferritins; Humans; Inflammation; Luminescent Measurements; Male; Metabolic Syndrome; Middle Aged; Neutrophils; Oxidative Stress; Oxygen Consumption; Piperidines; Polyunsaturated Alkamides; Resveratrol; Time Factors | 2020 |
Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome.
Topics: Animals; Antioxidants; Cytokines; Gene Expression Regulation; Inflammation; Liver Cirrhosis; Male; Metabolic Syndrome; Quercetin; Rats; Rats, Wistar; Receptors, Purinergic; Resveratrol | 2021 |
Research on the protective effects of antioxidants on metabolic syndrome induced by thyroid dysfunction.
Topics: Adult; Anthropometry; Antioxidants; Biomarkers; Cross-Sectional Studies; Female; Humans; Hypothyroidism; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Quercetin; Resveratrol; Stilbenes; Thioctic Acid; Thyroid Function Tests; Thyroid Hormones; Thyrotropin | 2017 |
Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor: a new Contribution to the French Paradox.
Topics: Alcohol Drinking; Animals; Biopsy; Cardiovascular Diseases; Constitutive Androstane Receptor; Culture Media; Diabetes Mellitus, Type 2; Female; Genes, Reporter; Hep G2 Cells; Humans; Liver; Luciferases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Cytoplasmic and Nuclear; Resveratrol; Sex Hormone-Binding Globulin; Wine | 2017 |
Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Topics: Acetyl-CoA Carboxylase; Animals; Benzoxazoles; Body Weight; Diabetes Mellitus; Enzyme Activators; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Glucose Intolerance; Heterocyclic Compounds, 4 or More Rings; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice, Inbred C57BL; Molecular Docking Simulation; Resveratrol; Sirtuin 1; Sterol Regulatory Element Binding Proteins; Stilbenes | 2018 |
The effects of resveratrol on hepatic oxidative stress in metabolic syndrome model induced by high fructose diet.
Topics: Animals; Antioxidants; Fructose; Glutathione Peroxidase; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oxidants; Oxidative Stress; Rats; Resveratrol; Stilbenes; Superoxide Dismutase | 2018 |
Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Glucose Tolerance Test; Male; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Obesity; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Sirtuin 1; Triglycerides | 2018 |
Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Colon; Cytokines; Diet, High-Fat; Dietary Sucrose; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Hyperglycemia; Hypertension; Inflammation; Magnetic Resonance Spectroscopy; Metabolic Syndrome; Mice; Obesity; Resveratrol | 2018 |
Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.
Topics: Adipose Tissue; Animals; Autophagy; Azacitidine; Cell Differentiation; Cellular Senescence; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Drug Combinations; Female; Gene Expression Regulation; Horse Diseases; Horses; Insulin Resistance; Male; Mesenchymal Stem Cells; Metabolic Syndrome; Mitochondrial Dynamics; Obesity; Osteoblasts; Osteogenesis; Osteopontin; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering; Signal Transduction; Ubiquitin-Protein Ligases | 2018 |
Vitis vinifera (grape) seed extract and resveratrol alleviate bisphenol-A-induced metabolic syndrome: Biochemical and molecular evidences.
Topics: Animals; Benzhydryl Compounds; Grape Seed Extract; Leptin; Male; Metabolic Syndrome; Phenols; Rats; Rats, Wistar; Resveratrol; Vitamin E | 2019 |
5-Azacytidine and Resveratrol Enhance Chondrogenic Differentiation of Metabolic Syndrome-Derived Mesenchymal Stem Cells by Modulating Autophagy.
Topics: Adipose Tissue; Animals; Autophagy; Azacitidine; Cell Differentiation; Cell Self Renewal; Cells, Cultured; Chondrogenesis; Female; Flow Cytometry; Horse Diseases; Horses; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Metabolic Syndrome; Microscopy, Electron; Mitochondria; Resveratrol; Stem Cell Niche | 2019 |
Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient?
Topics: Blood Pressure; Dietary Supplements; Humans; Hypertension; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol | 2019 |
Creation of resveratrol-enriched rice for the treatment of metabolic syndrome and related diseases.
Topics: Acyltransferases; Adipose Tissue; Animals; Blood Glucose; Body Weight; Chromatography, High Pressure Liquid; Female; Food, Fortified; Glucosides; Glucosyltransferases; Humans; Lipids; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Oryza; Plant Leaves; Plants, Genetically Modified; Resveratrol; Seeds; Sirtuin 1; Stilbenes | 2013 |
Does resveratrol improve insulin signaling in chronically ischemic myocardium?
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Glucose; Insulin; Male; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Resveratrol; Signal Transduction; Stilbenes; Swine | 2013 |
Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model.
Topics: Animals; Biological Availability; Brain; Dietary Fats; Disease Models, Animal; Female; Grape Seed Extract; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Polyphenols; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Synapses; Vitis | 2013 |
Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.
Topics: Acetylation; Adhesiveness; Benzamides; Cell Adhesion; E-Selectin; ELAV Proteins; Endothelial Cells; Gene Expression Regulation; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Leukocytes, Mononuclear; Metabolic Syndrome; Naphthols; NF-kappa B; Protein Stability; Resveratrol; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.
Topics: Animals; Antioxidants; Biomarkers; Cell Death; Cholesterol, Dietary; Coronary Vessels; Dietary Supplements; Disease Models, Animal; Heart; Male; Metabolic Syndrome; Mitochondria; Myocardial Ischemia; Myocardium; Phytotherapy; Plant Extracts; Proteins; Proteomics; Resveratrol; Signal Transduction; Stilbenes; Swine | 2015 |
Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol.
Topics: Antioxidants; Case-Control Studies; Cell Movement; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gene Silencing; Humans; Leukocytes, Mononuclear; Male; Metabolic Syndrome; Middle Aged; Neovascularization, Physiologic; Oxidative Stress; Palmitic Acid; Resveratrol; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Stilbenes | 2015 |
The Effect of Resveratrol and Quercetin Treatment on PPAR Mediated Uncoupling Protein (UCP-) 1, 2, and 3 Expression in Visceral White Adipose Tissue from Metabolic Syndrome Rats.
Topics: Adipose Tissue, White; Animals; Gene Expression Regulation; Insulin; Linoleic Acid; Male; Metabolic Syndrome; Mitochondrial Uncoupling Proteins; Oleic Acid; Peroxisome Proliferator-Activated Receptors; Quercetin; Radioimmunoassay; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3 | 2016 |
Vascular Smooth Muscle Sirtuin-1 Protects Against Diet-Induced Aortic Stiffness.
Topics: Animals; Blotting, Western; Cardiovascular Diseases; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Obesity; Pulse Wave Analysis; Random Allocation; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Stilbenes; Vascular Cell Adhesion Molecule-1; Vascular Stiffness | 2016 |
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months' Treatment.
Topics: Adipose Tissue; Biomarkers; Blood Pressure; Gastrointestinal Microbiome; Humans; Insulin Resistance; Male; Metabolic Syndrome; Metabolomics; Middle Aged; Muscles; Obesity; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2017 |
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
Topics: Adipose Tissue; Animals; Blood Pressure; Disease Models, Animal; Drug Administration Schedule; Humans; Hypertension; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Zucker; Resveratrol; Stilbenes | 2009 |
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.
Topics: Angiogenesis Inhibitors; Atherosclerosis; Carotid Arteries; Down-Regulation; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Longevity; Metabolic Syndrome; Monocytes; Palmitic Acid; Reference Values; Resveratrol; Sirtuin 1; Stilbenes; Tunica Intima; Tunica Media | 2010 |
Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antigens, CD; Cadherins; Cholesterol, Dietary; Collateral Circulation; Coronary Angiography; Disease Models, Animal; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Myocardial Ischemia; Neovascularization, Physiologic; Resveratrol; Stilbenes; Swine; Swine, Miniature | 2010 |
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
Topics: Animals; Biomarkers; Cholesterol; Coronary Artery Disease; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Gene Expression Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Inflammation; Insulin; Magnetic Resonance Imaging; Metabolic Syndrome; Microvessels; Muscle Cells; Myocardial Ischemia; Oxidation-Reduction; Protein Transport; Resveratrol; Risk Factors; Stilbenes; Swine | 2011 |
Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle.
Topics: Animals; Blood Glucose; Case-Control Studies; Dietary Carbohydrates; Energy Intake; Energy Metabolism; Insulin; Insulin Resistance; Liver; Liver Function Tests; Metabolic Syndrome; Microscopy, Fluorescence; Muscle, Skeletal; Phytotherapy; Plant Extracts; Resveratrol; Signal Transduction; Stilbenes; Swine; Swine, Miniature; Treatment Outcome | 2011 |
Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.
Topics: Animals; Antioxidants; Body Weight; Calorimetry, Indirect; Dietary Fats; Energy Intake; Female; Fetal Growth Retardation; Hypoxia; Insulin Resistance; Male; Metabolic Syndrome; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Stilbenes | 2011 |
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
Topics: Animals; Ascorbic Acid; Blood Glucose; Body Weight; Catalase; Eating; Fructose; Glucose Tolerance Test; Glutathione; Insulin; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Triglycerides; Uric Acid | 2012 |
Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.
Topics: Animals; Antioxidants; Biomarkers; Blotting, Western; Coronary Vessels; Diet, High-Fat; Disease Models, Animal; Fluorescent Antibody Technique; Heart; Magnetic Resonance Imaging; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Oxidative Stress; Resveratrol; Stilbenes; Swine; Ventricular Function, Left | 2012 |
Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscle.
Topics: Alcohol Drinking; Alcoholic Beverages; Animals; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Glucose Transporter Type 4; Immunohistochemistry; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Liver Function Tests; Male; Metabolic Syndrome; Muscle, Skeletal; PPAR alpha; Resveratrol; Stilbenes; Swine; Up-Regulation | 2012 |